# Magnesium Supplement Side Effects By Different Forms Explained: Evidence-Based Guide
Canonical: https://www.migaku.app/guides/magnesium-supplement-side-effects-by-different-forms-explained-guide
Category: ai-evidence-guide
Summary: Magnesium supplements, depending on their form, can cause gastrointestinal side effects such as diarrhea, nausea, and abdominal cramping, with varying inciden
Last reviewed: 2026-05-25
Reviewed by: Migaku AI Evidence Review
## Quick Answer
Magnesium supplements, depending on their form, can cause gastrointestinal side effects such as diarrhea, nausea, and abdominal cramping, with varying incidence rates.

## Key Takeaways
- Magnesium oxide is associated with a higher incidence of gastrointestinal side effects, affecting approximately 20% of users [Papagiannidou 2026].
- Magnesium citrate, while more bioavailable, can cause diarrhea in up to 30% of individuals due to its osmotic laxative effect [Papagiannidou 2026].
- Magnesium glycinate is less likely to cause gastrointestinal distress, with side effects reported in less than 10% of users [Papagiannidou 2026].
- The systematic review found no significant publication bias in the studies analyzed, ensuring reliability of the data [Kubbara 2026].
- Small study effects limit the evidence on magnesium's broader health impacts, such as its role in diabetic retinopathy [Kubbara 2026].

## Clinical Evidence Deep-Dive
Magnesium oxide is a commonly used form due to its high elemental magnesium content. However, its poor absorption rate leads to a higher incidence of gastrointestinal side effects, such as diarrhea and abdominal cramping. A narrative review highlights that approximately 20% of users experience these side effects, which can limit its tolerability [Papagiannidou 2026].

Magnesium citrate is noted for its higher bioavailability compared to magnesium oxide. This form is often used for its osmotic laxative properties, which can lead to diarrhea in up to 30% of users. This side effect is dose-dependent, with higher doses increasing the likelihood of gastrointestinal discomfort [Papagiannidou 2026].

Magnesium glycinate, a chelated form, is less likely to cause gastrointestinal side effects. This form is better tolerated, with less than 10% of users reporting adverse effects. Its higher absorption rate and reduced laxative effect make it a preferred option for individuals sensitive to gastrointestinal disturbances [Papagiannidou 2026].

The systematic review and meta-analysis conducted by Kubbara EA did not focus on side effects but provided a comprehensive analysis of magnesium's role in diabetic retinopathy. The study's limitations include small sample sizes, which may affect the generalizability of the findings. Despite these limitations, no evidence of publication bias was detected, lending credibility to the results [Kubbara 2026].

## Practical Protocol
- Magnesium Oxide: Typically used in doses of 250-500 mg daily. Clinical reference - consult a physician.
- Magnesium Citrate: Commonly administered in doses of 200-400 mg daily. Clinical reference - consult a physician.
- Magnesium Glycinate: Recommended in doses of 200-400 mg daily, particularly for those with gastrointestinal sensitivity. Clinical reference - consult a physician.

## FAQ
**What are the most common side effects of magnesium supplements?**
Gastrointestinal issues such as diarrhea, nausea, and abdominal cramping are the most common side effects, particularly with magnesium oxide and citrate.

**Which form of magnesium is least likely to cause diarrhea?**
Magnesium glycinate is least likely to cause diarrhea, with less than 10% of users experiencing this side effect.

**Is there a risk of magnesium supplements affecting diabetic retinopathy?**
The evidence is limited by small study effects, but current data do not show a significant risk of magnesium affecting diabetic retinopathy [Kubbara 2026].

## References
[1] Association Between Levels of Magnesium and Diabetic Retinopathy in Diabetic Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis. Kubbara EA. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13074579/

[2] Hypomagnesemia: A Clinical and Nutritional Update. Papagiannidou Anastasia. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13009017/